Myriad Genetics Inc
MYGNFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Myriad Genetics Inc Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 17 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 12, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Catalyst Funds Management Pty Ltd | 2026-03-31 | 33,980 | $153K | SEC filing |
| Sunbelt Securities, Inc. | 2026-03-31 | 178 | $801 | SEC filing |
| Tower Research Capital LLC (TRC) | 2026-03-31 | 20,402 | $91.8K | SEC filing |
| Susquehanna Portfolio Strategies, LLC | 2026-03-31 | 364,154 | $1.64M | SEC filing |
| STATE STREET CORP | 2026-03-31 | 4,424,027 | $19.9M | SEC filing |
| SBI Securities Co., Ltd. | 2026-03-31 | 1,005 | $4.52K | SEC filing |
| MARSHALL WACE, LLP | 2026-03-31 | 1,103,758 | $4.97M | SEC filing |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 2026-03-31 | 233,748 | $1.05M | SEC filing |
| KLP KAPITALFORVALTNING AS | 2026-03-31 | 19,900 | $89.6K | SEC filing |
| PICTON MAHONEY ASSET MANAGEMENT | 2026-03-31 | 43 | $194 | SEC filing |
| Assenagon Asset Management S.A. | 2026-03-31 | 1,446,961 | $6.51M | SEC filing |
| Owl Creek Wealth Partners LLC | 2026-03-31 | 950 | $4.28K | SEC filing |
| CANADA PENSION PLAN INVESTMENT BOARD | 2026-03-31 | 138,000 | $621K | SEC filing |
| Thrivent Financial for Lutherans | 2026-03-31 | 11,214 | Not shown | SEC filing |
| Brevan Howard Capital Management LP | 2026-03-31 | 21,333 | $96K | SEC filing |
| Headlands Technologies LLC | 2026-03-31 | 105,414 | $474K | SEC filing |
| CWM, LLC | 2026-03-31 | 71,153 | $320K | SEC filing |
| Physician Wealth Advisors, Inc. | 2026-03-31 | 1,758 | $7.91K | SEC filing |
| SG Americas Securities, LLC | 2026-03-31 | 51,865 | Not shown | SEC filing |
| Man Group plc | 2026-03-31 | 278,202 | $1.25M | SEC filing |
- Each value is checked against Myriad Genetics Inc's share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 2 rows: the filed value is about 1,000 times too small for the share count at Myriad Genetics Inc's share price.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Myriad Genetics Inc's recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2024-05-15 · DIAZ PAUL J: Larger than 15 of the 16 other insider sales of Common Stock on file. SEC filing
- 2024-05-14 · DIAZ PAUL J: Larger than all 16 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-08 | Kumar Rashmi · Director | Common Stock | S — Open market or private sale | −15,000 | 4.46 | SEC filing |
| 2026-05-14 | Bisaro Paul · Director | Common Stock | P — Open market or private purchase | +7,500 | 3.69 | SEC filing |
| 2026-03-09 | Raha Samraat S. · President and CEO | Common Stock | P — Open market or private purchase | +40,000 | 5.00 | SEC filing |
| 2026-02-27 | Phanstiel S. Louise · Director | Common Stock | P — Open market or private purchase | +48,000 | 4.66 | SEC filing |
| 2026-02-26 | Phanstiel S. Louise · Director | Common Stock | P — Open market or private purchase | +50,407 | 4.80 | SEC filing |
| 2026-02-25 | Phanstiel S. Louise · Director | Common Stock | P — Open market or private purchase | +6,100 | 4.74 | SEC filing |
| 2024-10-11 | DIAZ PAUL J · President and CEO | Common Stock | S — Open market or private sale | −15,000 | 22.93 | SEC filing |
| 2024-09-11 | Muzzey Dale · Chief Scientific Officer | Common Stock | S — Open market or private sale | −2,100 | 26.17 | SEC filing |
Showing 8 of 15 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-11 | Raha Samraat S. · President and CEO | Common Stock | A — Grant, award, or other acquisition | +3,542 | SEC filing |
| 2026-06-11 | Donnelly Brian J · Chief Commerical Officer | Common Stock | A — Grant, award, or other acquisition | +5,000 | SEC filing |
| 2026-06-04 | Newcomer Lee Nisley · Director | Common Stock | A — Grant, award, or other acquisition | +59,701 | SEC filing |
| 2026-06-04 | Bisaro Paul · Director | Common Stock | A — Grant, award, or other acquisition | +59,701 | SEC filing |
| 2026-06-04 | Skovronsky Daniel · Director | Common Stock | A — Grant, award, or other acquisition | +59,701 | SEC filing |
| 2026-06-04 | Phanstiel S. Louise · Director | Common Stock | A — Grant, award, or other acquisition | +59,701 | SEC filing |
| 2026-06-04 | Davis Mark Steven · Director | Common Stock | A — Grant, award, or other acquisition | +59,701 | SEC filing |
| 2026-06-04 | Reitan Colleen F · Director | Common Stock | A — Grant, award, or other acquisition | +59,701 | SEC filing |
Showing 8 of 20 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.